[{"data":1,"prerenderedAt":396},["ShallowReactive",2],{"slug-the-state-of-crispr-clinical-trials-and-their-future-potentials":3},{"post":4,"relatedPosts":160,"relatedBooks":306},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":32,"project_category":37,"contact_email_category":39,"yst_prominent_words":40,"class_list":43,"better_featured_image":56,"acf":88,"yoast_meta":105,"_links":107},53971,"2023-12-07T10:00:00","2023-12-07T09:00:00",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=53971&_wpnonce=dfdbbdb43b&status=auto-draft&type=post","2023-12-05T14:44:21","2023-12-05T13:44:21","the-state-of-crispr-clinical-trials-and-their-future-potentials","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fthe-state-of-crispr-clinical-trials-and-their-future-potentials",{"rendered":17},"The State Of CRISPR Clinical Trials And Their Future Potentials",{"rendered":19,"protected":20},"\n\u003Cp>CRISPR, short for “Clustered Regularly Interspaced Short Palindromic Repeats” – and more specifically CRISPR–Cas9 – relates to a gene-editing method that gained popularity \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fcrispr\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">in the past decade\u003C\u002Fa>; and not for trivial reasons. Being the most efficient and accurate method to edit a cell’s genome, CRISPR \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-could-crisprcas9-do-tomorrow\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">holds potentials\u003C\u002Fa> that range from treating conditions such as HIV to finding new drug targets.\u003C\u002Fp>\n\n\n\n\u003Cp>While such potentials \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.the-scientist.com\u002Fnews\u002Fnew-crispr-treatment-could-prevent-hiv-reinfection-after-viral-dna-excision-71284\" target=\"_blank\">are real\u003C\u002Fa> and are being \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.drugtargetreview.com\u002Farticle\u002F106588\u002Ffive-recent-crispr-drug-target-discoveries\u002F\" target=\"_blank\">actively investigated\u003C\u002Fa>, you might be curious about more practical examples of CRISPR applications. By taking the \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.clinicaltrials.gov\u002Fsearch?intr=CRISPR%2FCas9\" target=\"_blank\">US Clinical Trials registry\u003C\u002Fa> as an example, we consider listed clinical trials that involve CRISPR technology as of late November 2023. Such an undertaking can provide a better appreciation of the state of CRISPR potential, as well as practical use cases that we can expect in the coming years.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Clinical trials involving CRISPR \u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>For this analysis, we looked at the CRISPR entries on \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fclinicaltrials.gov\u002F\" target=\"_blank\">ClinicalTrials.gov\u003C\u002Fa>, which is an online database of clinical research studies and shares information about their results. This database is maintained by the United States National Library of Medicine at the National Institutes of Health and holds registrations from over 444,000 trials from 221 countries. At the time of writing, 51 CRISPR\u002FCas9-related studies were identified on ClinicalTrials.gov and they could roughly be categorised as completed, ongoing, or terminated based on their statuses.\u003C\u002Fp>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F051_genomsequence_v2-768x432.png\" alt=\"TMF genome DNA genetic test human jump\" class=\"wp-image-22404\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F051_genomsequence_v2-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F051_genomsequence_v2-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F051_genomsequence_v2-512x288.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F051_genomsequence_v2.png 870w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\u003C\u002Fdiv>\n\n\n\u003Ch3 class=\"wp-block-heading\">1. Completed CRISPR clinical trials\u003C\u002Fh3>\n\n\n\n\u003Cp>Considering that clinical trials can take \u003Ca href=\"https:\u002F\u002Fwww.cancerresearchuk.org\u002Fabout-cancer\u002Ffind-a-clinical-trial\u002Fhow-clinical-trials-are-planned-and-organised\u002Fhow-long-it-takes-for-a-new-drug-to-go-through-clinical-trials#:~:text=There%20is%20no%20typical%20length,a%20drug%20to%20be%20licensed.\" target=\"_blank\" rel=\"noreferrer noopener\">over 10 years to complete\u003C\u002Fa>, it is no surprise to see that from the database, the minority of the entries (only 6) are listed as complete. Most of them studied the safety and efficacy of potential new treatments involving CRISPR, whether it was modified cells or a new product targeting viral cells. \u003C\u002Fp>\n\n\n\n\u003Cp>For example, \u003Ca href=\"https:\u002F\u002Fwww.clinicaltrials.gov\u002Fstudy\u002FNCT02793856?intr=CRISPR%2FCas9&aggFilters=status:com&rank=3\" target=\"_blank\" rel=\"noreferrer noopener\">one completed Phase I clinical trial\u003C\u002Fa> involved CRISPR-edited T cells in patients with advanced non-small-cell lung cancer; with endpoints being the safety, feasibility and efficacy of these modified T cells. The results indicated that the clinical application of CRISPR gene-edited T cells is generally safe and feasible; while the therapeutic efficacy could be improved.\u003C\u002Fp>\n\n\n\n\u003Cp>Notably, half of the completed trials investigated interventions for advanced cancer types. The remaining involved either diabetes, viral eye infection or Kabuki syndrome (a rare genetic disorder).\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">2. Ongoing CRISPR clinical trials\u003C\u002Fh3>\n\n\n\n\u003Cp>The vast majority of the CRISPR clinical trials on the database, or 30 of them, are ongoing, whether they are actively recruiting or not. They are mostly investigating the safety of CRISPR-based therapies either for cancer treatment ranging from renal cell carcinoma to lymphomas or genetic disorders such as thalassemia and sickle cell disease.\u003C\u002Fp>\n\n\n\n\u003Cp>To illustrate one of the areas of focus, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.clinicaltrials.gov\u002Fstudy\u002FNCT04208529?intr=CRISPR%2FCas9&aggFilters=status:not%20rec%20act%20enr&rank=25\" target=\"_blank\">one of the listed trials\u003C\u002Fa> is following up with patients who received CRISPR-modified hematopoietic stem infusion for either β-thalassemia or severe sickle cell disease. The aim is to determine the long-term safety and efficacy of the treatment. In particular, the researchers are interested in determining the occurrence of new or worsening conditions, as well as severe adverse events up to 15 years after the treatment.\u003C\u002Fp>\n\n\n\n\u003Cp>As for the remaining trials, one is studying the effects of CRISPR-modified pancreatic cells for Type 1 diabetic patients; and another trial is investigating a new CRISPR-based drug for HIV treatment.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">3. Terminated CRISPR clinical trials \u003C\u002Fh3>\n\n\n\n\u003Cp>15 of the entries are either labeled as terminated, suspended, withdrawn or have an unknown status. Nearly all of them investigated the treatment of cancers, but their outcomes will likely remain unknown considering the statuses of the trials. \u003C\u002Fp>\n\n\n\n\u003Cp>As there are some overlaps with conditions of focus in ongoing trials, the less positive outcomes of terminated trials do not mean that other therapies aren’t possible. It means the approach of a certain trial did not pan out as initially planned, which could be due to several causes from lack of funding to poor recruitment of participants. \u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">What to expect from CRISPR in healthcare\u003C\u002Fh2>\n\n\n\n\u003Cp>As the database indicates, CRISPR’s potential to devise new treatments is actively being investigated by researchers. In particular, we can expect a more significant impact of CRISPR in the potential treatment of cancers and genetic disorders, as the majority of trials currently have such a focus. Interest in such conditions is understandable considering that there are \u003Ca href=\"https:\u002F\u002Fwww.wcrf.org\u002Fcancer-trends\u002Fworldwide-cancer-data\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">over 18 million cancer cases worldwide\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1110863011000620\" target=\"_blank\" rel=\"noreferrer noopener\">2–5% of all live births\u003C\u002Fa> are affected by hereditary diseases.\u003C\u002Fp>\n\n\n\n\u003Cp>However, CRISPR-based treatments for less prevalent conditions are also gaining interest. For instance, the database lists \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.clinicaltrials.gov\u002Fstudy\u002FNCT03855631?intr=CRISPR%2FCas9&aggFilters=status:com&rank=4\" target=\"_blank\">a completed observational study\u003C\u002Fa> around gene therapy for Kabuki syndrome, a rare genetic condition that affects children at \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpmc\u002Farticles\u002FPMC9601850\u002F\" target=\"_blank\">an estimated frequency\u003C\u002Fa> of 1:32,000 to 1:86,000. This indicates that the efficacy of CRISPR-based therapies could be assessed for a wider pool of conditions in the coming years. \u003C\u002Fp>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1800\" height=\"1012\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F10\u002Ftmf_article_335-v2-01.png\" alt=\"TMF DNA sequence\" class=\"wp-image-47669\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F10\u002Ftmf_article_335-v2-01.png 1800w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F10\u002Ftmf_article_335-v2-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F10\u002Ftmf_article_335-v2-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F10\u002Ftmf_article_335-v2-01-1536x864.png 1536w\" sizes=\"auto, (max-width: 1800px) 100vw, 1800px\" \u002F>\u003C\u002Ffigure>\n\u003C\u002Fdiv>\n\n\n\u003Cp>It should be noted that even if a trial has been completed, the proposed therapy might undergo further rounds of assessments to minimize identified risks and side effects. Furthermore, upon completion of clinical trials, the treatment will need to get approval from relevant health authorities. This means more time before seeing marketable solutions for everyday patients.\u003C\u002Fp>\n\n\n\n\u003Cp>But we might be on the cusp of having CRISPR-based treatments become more widely available. The technology has been refined, with the potential to be more specific and applied for common diseases such as \u003Ca href=\"https:\u002F\u002Fwww.technologyreview.com\u002F2023\u002F01\u002F09\u002F1064857\u002Fcrispr-high-cholesterol-10-breakthrough-technologies-2023\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">high cholesterol\u003C\u002Fa>. In late November 2023, the world’s first CRISPR therapy \u003Ca href=\"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fd41587-023-00016-6\" target=\"_blank\" rel=\"noreferrer noopener\">was approved\u003C\u002Fa> by the UK’s regulator. Named Casgevy, the treatment is aimed at sickle cell disease and transfusion-dependent β-thalassemia. \u003C\u002Fp>\n\n\n\n\u003Cp>This is promising progress considering that CRISPR–Cas9 gene editing therapy was \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.science.org\u002Fdoi\u002F10.1126\u002Fscience.1225829\" target=\"_blank\">introduced 11 years ago\u003C\u002Fa>. More might follow suit soon, enabling patients to benefit from treatments for otherwise incurable conditions. \u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó & Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n",false,{"rendered":22,"protected":20},"\u003Cp>We analyzed current CRISPR clinical trials, their impact on healthcare, as well as the potential and challenges of such  therapies.\u003C\u002Fp>\n",16,54001,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31],7079,[33,34,35,36],570,904,7891,566,[38],950,[],[41,42],1621,1635,[44,14,45,46,47,48,49,50,51,52,53,54,55],"post-53971","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tmf","tag-crispr","tag-gene-editing","tag-crispr-therapy","tag-clinical-trials","project_category-medical-professionals",{"id":24,"alt_text":57,"caption":27,"description":27,"media_type":58,"media_details":59,"post":5,"source_url":87},"gene editing, CRISPR, DNA","image",{"width":60,"height":61,"file":62,"filesize":63,"sizes":64,"image_meta":84},1520,855,"2023\u002F12\u002Ftmf_article_393_CRISPR_gene_editing.png",1377624,{"medium":65,"large":72,"thumbnail":78,"medium_large":83},{"file":66,"width":67,"height":68,"mime-type":69,"filesize":70,"source_url":71},"tmf_article_393_CRISPR_gene_editing-370x208.png",370,208,"image\u002Fpng",70304,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F12\u002Ftmf_article_393_CRISPR_gene_editing-370x208.png",{"file":73,"width":74,"height":75,"mime-type":69,"filesize":76,"source_url":77},"tmf_article_393_CRISPR_gene_editing-768x432.png",768,432,277045,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F12\u002Ftmf_article_393_CRISPR_gene_editing-768x432.png",{"file":79,"width":80,"height":80,"mime-type":69,"filesize":81,"source_url":82},"tmf_article_393_CRISPR_gene_editing-150x150.png",150,25114,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F12\u002Ftmf_article_393_CRISPR_gene_editing-150x150.png",{"file":73,"width":74,"height":75,"mime-type":69,"filesize":76,"source_url":77},{"aperture":85,"credit":27,"camera":27,"caption":27,"created_timestamp":85,"copyright":27,"focal_length":85,"iso":85,"shutter_speed":85,"title":27,"orientation":85,"keywords":86},"0",[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F12\u002Ftmf_article_393_CRISPR_gene_editing.png",{"cta_type":89,"cta_color":27,"subtitle":27,"key_takeaways":90,"related_books":97,"related_posts_footer":101,"related_posts":20},"subscribe",[91,93,95],{"title":92},"\u003Cp>CRISPR technology has progressed significantly in clinical trials, showing promising results particularly in treating advanced cancers and genetic disorders like thalassemia and sickle cell disease\u003C\u002Fp>\n",{"title":94},"\u003Cp>Despite some trials being terminated, ongoing research continues to explore the safety and efficacy of CRISPR-based therapies, indicating a strong future potential in healthcare.\u003C\u002Fp>\n",{"title":96},"\u003Cp>The recent approval of the world’s first CRISPR therapy for sickle cell disease and β-thalassemia marks a significant milestone, heralding a new era of gene-editing treatments for a range of conditions.\u003C\u002Fp>\n",[98,99,100],24765,52203,24761,[102,103,104],27125,13277,53799,{"yoast_wpseo_title":17,"yoast_wpseo_metadesc":106,"yoast_wpseo_canonical":15},"We analyzed current CRISPR clinical trials, their impact on healthcare, as well as the potential and challenges of such therapies.",{"self":108,"collection":114,"about":117,"author":120,"replies":123,"version-history":126,"predecessor-version":130,"wp:featuredmedia":134,"wp:attachment":137,"wp:term":140,"curies":156},[109],{"href":110,"targetHints":111},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F53971",{"allow":112},[113],"GET",[115],{"href":116},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[118],{"href":119},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[121],{"embeddable":26,"href":122},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F16",[124],{"embeddable":26,"href":125},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=53971",[127],{"count":128,"href":129},15,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F53971\u002Frevisions",[131],{"id":132,"href":133},54057,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F53971\u002Frevisions\u002F54057",[135],{"embeddable":26,"href":136},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F54001",[138],{"href":139},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=53971",[141,144,147,150,153],{"taxonomy":142,"embeddable":26,"href":143},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=53971",{"taxonomy":145,"embeddable":26,"href":146},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=53971",{"taxonomy":148,"embeddable":26,"href":149},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=53971",{"taxonomy":151,"embeddable":26,"href":152},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=53971",{"taxonomy":154,"embeddable":26,"href":155},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=53971",[157],{"name":158,"href":159,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[161],{"id":104,"date":162,"date_gmt":163,"guid":164,"modified":166,"modified_gmt":167,"slug":168,"status":13,"type":14,"link":169,"title":170,"content":172,"excerpt":174,"author":176,"featured_media":177,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":178,"categories":179,"tags":182,"project_category":187,"contact_email_category":190,"yst_prominent_words":191,"class_list":201,"better_featured_image":211,"acf":246,"yoast_meta":261,"_links":263},"2025-07-07T10:32:00","2025-07-07T08:32:00",{"rendered":165},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=53799&_wpnonce=4709dd64cd&status=auto-draft&type=post","2025-07-07T10:32:01","2025-07-07T08:32:01","what-do-we-need-to-have-ai-equipped-nanobots-in-medicine","https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-do-we-need-to-have-ai-equipped-nanobots-in-medicine",{"rendered":171},"What Do We Need To Have AI-Equipped Nanobots In Medicine",{"rendered":173,"protected":20},"\n\u003Cblockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n\u003Cp>Disease, noun [archaic]: A historical term used to describe various physical and mental ailments that affected organisms, primarily humans, in an era before the advent of comprehensive nanomedical and genetic interventions. In the technologically primitive past, diseases were common causes of discomfort, dysfunction, and mortality, often requiring medical treatment and care. Modern advances and nanobots in medicine have rendered this term obsolete, as conditions previously classified as diseases are now either preventable or entirely curable at the molecular level.\u003C\u002Fp>\n\u003C\u002Fblockquote>\n\n\n\n\u003Cp>Are we on the brink of a brave new world where diseases are just thrilling concepts from ancient history? After all, we are living through an \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhy-it-is-important-to-understand-multimodal-large-language-models-in-healthcare\" target=\"_blank\" rel=\"noreferrer noopener\">AI revolution\u003C\u002Fa> and nanotechnology captures our imaginations, it’s a natural expectation that these two fields will converge. The integration of AI and nanotechnology is seen as the next frontier, promising a future where AI-powered nanobots operate at a molecular level, transforming everything from healthcare to material science. \u003C\u002Fp>\n\n\n\n\u003Cp>If we wonder what such AI-powered nanobots could do for us, we find a list of mindblowing possibilities. \u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Diseases are unknown, death is an archaic term \u003C\u002Fh2>\n\n\n\n\u003Cp>According to sci-fi novels and sensationalist reporters, we’ll soon be living in an age where diseases will be a thing of the past with nanobots continuously monitoring the body’s internal environment for early signs of diseases, such as cancer, infections, or autoimmune disorders. They could detect anomalies at the cellular level long before symptoms manifest, allowing for early intervention.\u003C\u002Fp>\n\n\n\n\u003Cp>If our nanobots send an alert about cancerous cells, we’d have no reason to worry. Our doctor would quickly design the suiting drugs that nanobots administer directly to targeted areas, increasing treatment efficacy and minimizing side effects. \u003C\u002Fp>\n\n\n\n\u003Cp>In this new world, nanobots could be programmed to repair genetic mutations or defects in situ, cure genetic diseases, or enhance physical or cognitive abilities. We would be offered neural enhancement: nanobots could interface with the nervous system, enhancing cognitive functions like memory, learning, and processing speed. \u003C\u002Fp>\n\n\n\n\u003Cp>Aging would be obviously unknown: nanobots could repair or replace aged cells and tissues. They could also promote regeneration, healing injuries, and wounds at an accelerated rate. We would be in top shape as our nanoscale allies would be detoxifying our bodies, regulating metabolism, and helping in maintaining optimal body weight and nutrient balance.\u003C\u002Fp>\n\n\n\n\u003Cp>And our stellar form would not only be physical: by monitoring and adjusting neurochemical levels, nanobots could help in managing mental health conditions like depression or anxiety, potentially providing alerts or interventions during mental health crises.\u003C\u002Fp>\n\n\n\n\u003Cp>Not to mention the fact that if needed, nanobots could enhance our strength and endurance, or even provide capabilities like underwater breathing or enhanced sensory perception.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_386-768x432.png\" alt=\"\" class=\"wp-image-52741\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_386-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_386-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_386-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_386.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Are we there yet? \u003C\u002Fh2>\n\n\n\n\u003Cp>Nanomedicine is an innovative field where nanotechnology is applied to healthcare. It leverages the unique properties of materials at the nanoscale (10^-9 meters), which often exhibit different physical, chemical, or biological characteristics compared to the same materials at a larger scale. This nanoscale is also similar to the scale of many biological mechanisms in the human body, allowing nanoparticles and nanomaterials to potentially cross natural barriers and interact with DNA or small proteins.\u003C\u002Fp>\n\n\n\n\u003Cp>This is an intriguing segment, with some very hands-on progress: according to the \u003Ca href=\"https:\u002F\u002Fetp-nanomedicine.eu\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Nanomedicine European Technology Platform\u003C\u002Fa>, there are over 80 marketed products, ranging from nano-delivery and pharmaceutical to medical imaging, diagnostics and biomaterials.\u003C\u002Fp>\n\n\n\n\u003Cp>The \u003Ca href=\"https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpmc\u002Farticles\u002FPMC6982820\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">first nanotechnology-based targeted drug delivery systems\u003C\u002Fa> are already on the market, others are in clinical trials or, by far the largest part, are under development. Another highly attractive area of nanomedicine is diagnostics at nanoscale. \u003C\u002Fp>\n\n\n\n\u003Cp>The aim is to identify a disease at the earliest possible stage. Already today artificial skin, bone, and cartilage are in an advanced stage of development and partly already on the market.\u003C\u002Fp>\n\n\n\n\u003Cp>In the past two decades, many great minds labored to get us closer to nanobots, and we have great concepts, like the \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.thekurzweillibrary.com\u002Fclottocytes-artificial-mechanical-platelets#:~:text=Nanorobotic%20artificial%20mechanical%20platelets%20(%E2%80%9Cclottocytes,They%20could%20also%20work%20internally.\" target=\"_blank\">blood-clotting Clottocytes\u003C\u002Fa>, oxygen-carrying \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FRespirocyte\" target=\"_blank\">Respirocytes\u003C\u002Fa>, or \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.theguardian.com\u002Fwhat-is-nano\u002Fnano-and-the-life-saving-future-of-medicine\" target=\"_blank\">Microbivores\u003C\u002Fa>, also known as nanorobotic phagocytes, that act as artificial white blood cells.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_385-768x432.png\" alt=\"medical specialties TMF\" class=\"wp-image-52411\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_385-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_385-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_385-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F09\u002Ftmf_article_385.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Nanomedicine may be in our sight, AI nanobots are not\u003C\u002Fh2>\n\n\n\n\u003Cp>A future without aging, diseases, and mental problems is fascinating, no wonder AI nanobots make so many of us excited. But if you ask me how close we are to this health utopia, I’ll be the bearer of bad news: \u003Cstrong>I think we are not close at all. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>The concept of AI-equipped nanobots in our bloodstream remains far from realisation due to a variety of scientific, technological, and ethical challenges. Here are five reasons why we don’t have such technology today and why it’s unlikely to be developed within the – at least – next decade.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">1. Technological Limitations: \u003C\u002Fh3>\n\n\n\n\u003Cp>Creating nanobots equipped with AI that can safely and effectively operate in the human bloodstream involves immense technological challenges. This includes miniaturizing components to a nanoscale while ensuring they have enough power to operate and communicate. We currently only have existing examples on a microscale. As of now, we lack the necessary technology to build and power such tiny, sophisticated devices.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">2. Biocompatibility and Safety Issues: \u003C\u002Fh3>\n\n\n\n\u003Cp>Ensuring that nanobots are biocompatible and do not provoke an immune response is a significant challenge. There’s also the risk of unintended interactions with biological systems, such as clotting, inflammation, or accidental damage to cells or DNA, which could lead to serious health consequences.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">3. AI and Robotics Development Stage: \u003C\u002Fh3>\n\n\n\n\u003Cp>Current AI and robotics technologies are not yet advanced enough to autonomously perform complex tasks inside the human body. AI systems, especially those that would need to operate at a nanoscale, require further development to handle the unpredictable and complex environment of the human body. Plus how would we provide energy for it?\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">4. Ethical and Regulatory Concerns: \u003C\u002Fh3>\n\n\n\n\u003Cp>There are numerous ethical and regulatory hurdles to overcome. The use of such technology raises questions about privacy (such as data collection from within the body), consent, and potential misuse. Additionally, regulatory bodies like the FDA would require extensive testing and trials to ensure safety and efficacy, which is a long and rigorous process. If an insulin pump can be hacked, imagine the level of issues around something in our bloodstream. \u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">5. Cost and Accessibility: \u003C\u002Fh3>\n\n\n\n\u003Cp>The development and deployment of AI-equipped nanobots would be extremely expensive. This cost barrier means that even if the technology were available, it might not be accessible to the majority of the population, leading to ethical concerns about equity and justice in healthcare. A blood test is still much more feasible than building nanobots.\u003C\u002Fp>\n\n\n\n\u003Cp>Given these challenges, it’s unlikely that we will see AI-equipped nanobots being used in medical applications within the next decade. Advances in related fields like nanotechnology, biotechnology, and AI are needed before such an ambitious project could become feasible.\u003C\u002Fp>\n\n\n\n\u003Cp>Also, if people are afraid of a robot that \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwould-you-let-a-robot-take-your-blood-sample\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">can take a blood sample\u003C\u002Fa>, would they allow robots to live inside their bloodstream? I highly doubt it.\u003C\u002Fp>\n",{"rendered":175,"protected":20},"\u003Cp>According to sensationalist reporters we’ll soon be living in an age where diseases will be a thing of the past thanks to AI nanobots. But how close are we? Let’s bust some myths here.\u003C\u002Fp>\n",6,53803,{"_acf_changed":20,"footnotes":27},[31,180,181],521,507,[183,184,185,186],246,7011,7889,134,[38,188,189],951,952,[],[192,193,194,195,196,197,198,199,200],2329,2731,3271,4959,1559,1569,1719,1833,2297,[202,14,45,46,47,48,49,50,203,204,205,206,207,208,55,209,210],"post-53799","category-future-medicine","category-nanotechnology","tag-future","tag-nanobots","tag-nanobots-in-medicine","tag-ai","project_category-patients","project_category-policy-makers",{"id":177,"alt_text":27,"caption":27,"description":27,"media_type":58,"media_details":212,"post":104,"source_url":245},{"width":213,"height":214,"file":215,"filesize":216,"sizes":217,"image_meta":243},3200,1800,"2023\u002F11\u002Ftmf_article_392_nanobots.png",1052693,{"medium":218,"large":222,"thumbnail":226,"medium_large":230,"1536x1536":231,"2048x2048":237},{"file":219,"width":67,"height":68,"mime-type":69,"filesize":220,"source_url":221},"tmf_article_392_nanobots-370x208.png",50963,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002Ftmf_article_392_nanobots-370x208.png",{"file":223,"width":74,"height":75,"mime-type":69,"filesize":224,"source_url":225},"tmf_article_392_nanobots-768x432.png",136592,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002Ftmf_article_392_nanobots-768x432.png",{"file":227,"width":80,"height":80,"mime-type":69,"filesize":228,"source_url":229},"tmf_article_392_nanobots-150x150.png",19134,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002Ftmf_article_392_nanobots-150x150.png",{"file":223,"width":74,"height":75,"mime-type":69,"filesize":224,"source_url":225},{"file":232,"width":233,"height":234,"mime-type":69,"filesize":235,"source_url":236},"tmf_article_392_nanobots-1536x864.png",1536,864,358837,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002Ftmf_article_392_nanobots-1536x864.png",{"file":238,"width":239,"height":240,"mime-type":69,"filesize":241,"source_url":242},"tmf_article_392_nanobots-2048x1152.png",2048,1152,554441,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002Ftmf_article_392_nanobots-2048x1152.png",{"aperture":85,"credit":27,"camera":27,"caption":27,"created_timestamp":85,"copyright":27,"focal_length":85,"iso":85,"shutter_speed":85,"title":27,"orientation":85,"keywords":244},[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002Ftmf_article_392_nanobots.png",{"cta_type":89,"cta_color":27,"related_books":247,"related_posts_footer":250,"related_posts":20,"subtitle":27,"key_takeaways":254},[248,249,99],24759,30419,[251,252,253],53187,53089,53645,[255,257,259],{"title":256},"\u003Cp>\u003Cspan style=\"font-weight: 400;\">AI nanobots promise a future where diseases could become obsolete, thanks to early disease detection, treatment at a cellular level, and enhancement of physical and cognitive abilities – according to the picture painted by sci-fi writers.\u003C\u002Fspan>\u003C\u002Fp>\n",{"title":258},"\u003Cp>\u003Cspan style=\"font-weight: 400;\">We have significant progress on the micro-level, but the nanoworld is still further away, although we see some progress in areas like nanomedicine.\u003C\u002Fspan>\u003C\u002Fp>\n",{"title":260},"\u003Cp>\u003Cspan style=\"font-weight: 400;\">Despite the exciting possibilities, AI-equipped nanobots in our bloodstream are at least a decade (if not more) away due to technological, biocompatibility, ethical, and regulatory challenges.\u003C\u002Fspan>\u003C\u002Fp>\n",{"yoast_wpseo_title":171,"yoast_wpseo_metadesc":262,"yoast_wpseo_canonical":169},"According to sensationalist reports diseases will soon be a thing of the past thanks to AI nanobots in medicine. But how close are we?",{"self":264,"collection":269,"about":271,"author":273,"replies":276,"version-history":279,"predecessor-version":283,"wp:featuredmedia":287,"wp:attachment":290,"wp:term":293,"curies":304},[265],{"href":266,"targetHints":267},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F53799",{"allow":268},[113],[270],{"href":116},[272],{"href":119},[274],{"embeddable":26,"href":275},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F6",[277],{"embeddable":26,"href":278},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=53799",[280],{"count":281,"href":282},19,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F53799\u002Frevisions",[284],{"id":285,"href":286},53849,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F53799\u002Frevisions\u002F53849",[288],{"embeddable":26,"href":289},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F53803",[291],{"href":292},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=53799",[294,296,298,300,302],{"taxonomy":142,"embeddable":26,"href":295},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=53799",{"taxonomy":145,"embeddable":26,"href":297},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=53799",{"taxonomy":148,"embeddable":26,"href":299},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=53799",{"taxonomy":151,"embeddable":26,"href":301},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=53799",{"taxonomy":154,"embeddable":26,"href":303},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=53799",[305],{"name":158,"href":159,"templated":26},[307],{"id":100,"date":308,"date_gmt":309,"guid":310,"modified":312,"modified_gmt":313,"slug":314,"status":13,"type":315,"link":316,"title":317,"content":319,"excerpt":321,"author":323,"featured_media":324,"comment_status":25,"ping_status":25,"template":27,"yst_prominent_words":325,"class_list":328,"better_featured_image":331,"acf":349,"yoast_meta":365,"_links":367},"2023-11-01T15:46:07","2023-11-01T14:46:07",{"rendered":311},"https:\u002F\u002Fapi.medicalfuturist.com\u002F?post_type=book&p=24761","2023-11-01T15:46:17","2023-11-01T14:46:17","tech-giants-in-healthcare","book","https:\u002F\u002Fapi.medicalfuturist.com\u002Fbooks\u002Ftech-giants-in-healthcare\u002F",{"rendered":318},"Tech Giants in Healthcare – Updated Edition",{"rendered":320,"protected":20},"\n\u003Cp>This comprehensive guide, Tech Giants in Healthcare, clarifies how and why big tech companies step into healthcare, and breaks it down from one market player to the other in what direction they are going, what tools they are using and what horizons they have in front of them.\u003C\u002Fp>\n",{"rendered":322,"protected":20},"\u003Cp>This comprehensive guide, Tech Giants in Healthcare, clarifies how and why big tech companies step into healthcare, and breaks it down from one market player […]\u003C\u002Fp>\n",10,53261,[326,327],1683,1595,[329,315,330,46,48,49],"post-24761","type-book",{"id":324,"alt_text":27,"caption":27,"description":27,"media_type":58,"media_details":332,"post":100,"source_url":348},{"width":333,"height":334,"file":335,"filesize":336,"sizes":337,"image_meta":346},700,906,"2020\u002F05\u002F1031_techgiants_2023-5-1-1.png",1092124,{"medium":338,"thumbnail":342},{"file":339,"width":67,"height":68,"mime-type":69,"filesize":340,"source_url":341},"1031_techgiants_2023-5-1-1-370x208.png",112044,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-1-370x208.png",{"file":343,"width":80,"height":80,"mime-type":69,"filesize":344,"source_url":345},"1031_techgiants_2023-5-1-1-150x150.png",42366,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-1-150x150.png",{"aperture":85,"credit":27,"camera":27,"caption":27,"created_timestamp":85,"copyright":27,"focal_length":85,"iso":85,"shutter_speed":85,"title":27,"orientation":85,"keywords":347},[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-1.png",{"leanpub_url":350,"buy_button_text":351,"preview":352},"https:\u002F\u002Fleanpub.com\u002Ftech-giants-in-healthcare","Get it on Leanpub",[353,355,357,359,361,363],{"image":354},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-10-01.png",{"image":356},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-10-02.png",{"image":358},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-10-03.png",{"image":360},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-10-04.png",{"image":362},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-10-05.png",{"image":364},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002F1031_techgiants_2023-5-1-10-06.png",{"yoast_wpseo_title":366,"yoast_wpseo_metadesc":27,"yoast_wpseo_canonical":316},"Tech Giants in Healthcare - Updated Edition - The Medical Futurist",{"self":368,"collection":373,"about":376,"author":379,"replies":382,"wp:featuredmedia":385,"wp:attachment":388,"wp:term":391,"curies":394},[369],{"href":370,"targetHints":371},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook\u002F24761",{"allow":372},[113],[374],{"href":375},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook",[377],{"href":378},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fbook",[380],{"embeddable":26,"href":381},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F10",[383],{"embeddable":26,"href":384},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=24761",[386],{"embeddable":26,"href":387},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F53261",[389],{"href":390},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=24761",[392],{"taxonomy":154,"embeddable":26,"href":393},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=24761",[395],{"name":158,"href":159,"templated":26},1785514521982]